Marketing-authorisation holder · United States
Prinston Inc
10 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BISOPROLOL FUMARATE10mg | 2.5mg | 5mg · Tablet | Bisoprolol | United States | Marketed | 2000 |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE12.5mg; 10mg | 12.5mg; 20mg | 25mg; 20mg · Tablet | Hydrochlorothiazide, Lisinopril | United States | Marketed | 2002 |
| PAROXETINE10mg base | 20mg base | 30mg base | 40mg base · Tablet | Paroxetine | United States | Marketed | 2014 |
| PAROXETINE MESYLATE7.5mg base · Capsule | Paroxetine | United States | Marketed | 2017 |
| VORICONAZOLE200mg | 50mg · Tablet | Voriconazole | United States | Marketed | 2010 |
| VYDUO5mg base; 80mg · Tablet | Nebivolol, Valsartan | United States | Marketed | 2022 |
| EMPAGLIFLOZIN AND LINAGLIPTIN10mg; 5mg | 25mg; 5mg · Tablet | Empagliflozin, Linagliptin | United States | tentative | 2020 |
| SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE1000mg | 500mg | 50mg · Tablet | Metformin, Sitagliptin | United States | tentative | 2025 |
| TOFACITINIB10mg | 5mg · Tablet | Tofacitinib | United States | tentative | 2022 |
| VORTIOXETINE10mg | 15mg | 20mg | 5mg · Tablet | Vortioxetine | United States | tentative | 2019 |